Ugur Sahin, CEO of BioNTech SE, sold 39,000 shares of $BNTX common stock on September 24, 2026, at $98.9913 per share, for a total of $3,860,660.70. The Form 4 was filed the same day and identified the transaction as an open-market sale. Sahin reported 341,209 shares owned after the transaction.
The sale was the sixth open-market sale Sahin reported during September. On September 15, he sold 34,000 shares at $96.4893 for $3,280,636.20, leaving 568,209 shares. On September 16, he sold 15,000 shares at $96.0893 for $1,441,339.50, leaving 553,209 shares. On September 17, he sold 34,000 shares at $98.5983 for $3,352,342.20, leaving 519,209 shares. On September 18, he sold 30,000 shares at $96.2243 for $2,886,729.00, leaving 489,209 shares. On September 23, he sold 30,000 shares at $99.4027 for $2,982,081.00, leaving 380,209 shares; that filing was dated September 24, one day after the trade. The September 24 sale reduced the reported holding to 341,209 shares. Across the six sales, Sahin sold 182,000 shares for $17,803,788.60.
Filing dates for the September transactions varied. The September 15 and 16 trades were filed on September 16; the September 17 and 18 trades were filed on September 18; the September 23 and 24 trades were filed on September 24. The September 24 sale was therefore reported the same day it occurred.
Daily price records show $BNTX closed at $96.69 on September 15, $95.83 on September 16, $98.66 on September 17, $96.06 on September 18, $98.00 on September 21, $100.87 on September 22, and $98.46 on September 23.
BioNTech's Form 4 records also show a separate open-market sale earlier in 2026. On April 22, COO Sierk Poetting sold 50,000 shares at $110.5592 per share, for $5,527,960.00, with the filing dated April 23. Poetting reported 399,387 shares owned after that transaction.
Congressional STOCK Act disclosures for $BNTX also appear in the database. Representative Josh Gottheimer, a Democrat in the House, reported purchases on December 5, 6, and 7, 2023, and April 15, 2024, and sales on March 14, August 30, and September 3, 2024. Representative Valerie Hoyle, a Democrat in the House, reported a sale on August 7, 2025. Representative Ro Khanna, a Democrat in the House, reported a sale on January 20, 2022. Those filings disclose bracketed dollar ranges rather than exact share counts. The most recent congressional $BNTX disclosure in the database was Representative Valerie Hoyle's August 7, 2025 sale.
BioNTech SE is classified in the biotechnology sector, and the companies table lists its market capitalization at $25,338,985,088. The September 24 filing listed Sahin's role as CEO and his reporting-owner CIK as 2123975.